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ABSTRACT
RNA-binding proteins (RBPs) regulate gene expres-
sion at many post-transcriptional levels, including
mRNA stability and translation. The RBP nucleolin,
with four RNA-recognition motifs, has been
implicated in cell proliferation, carcinogenesis and
viral infection. However, the subset of nucleolin
target mRNAs and the influence of nucleolin on
their expression had not been studied at a
transcriptome-wide level. Here, we globally
identified nucleolin target transcripts, many of
which encoded cell growth- and cancer-related
proteins, and used them to find a signature motif
on nucleolin target mRNAs. Surprisingly, this motif
was very rich in G residues and was not only found
in the 30-untranslated region (UTR), but also in the
coding region (CR) and 50-UTR. Nucleolin enhanced
the translation of mRNAs bearing the G-rich motif,
since silencing nucleolin did not change target
mRNA stability, but decreased the size of poly-
somes forming on target transcripts and lowered
the abundance of the encoded proteins. In
summary, nucleolin binds G-rich sequences in the
CR and UTRs of target mRNAs, many of which
encode cancer proteins, and enhances their
translation.
INTRODUCTION
In mammalian cells, RNA-binding proteins (RBPs)
robustly modulate gene expression by controlling
post-transcriptional processes like pre-mRNA splicing
and maturation, mRNA transport, stability and transla-
tion (1–5). Some RBPs are specialized in one particular
aspect of mRNA metabolism; for example, the RBPs
tristetraprolin (TTP) and KH-type splicing regulatory
protein (KSRP) promote mRNA degradation (6–8).
However, most RBPs inﬂuence the fate of target tran-
scripts in multiple ways; for example, the embryonic
lethal abnormal vision (elav)/Hu protein HuR stabilizes
some target mRNAs, but modulates the translation of
other targets (9), AUF1 (AU-binding factor 1)/
hnRNP D (heterogeneous nuclear ribonucleoprotein D)
modulates the stability and translation of several target
transcripts (10–13), T-cell intracellular antigen-1 (TIA-1)
and TIA-1-related protein (TIAR) participate in the
splicing and translational repression of target transcripts
(14–16), while the polypyrimidine tract-binding protein
(PTB) can modulate splicing, stability and translation of
target RNAs (17,18). Yet, other RBPs such as the nuclear
factor (NF)90 (also named NFAR, DRBP76 and ILF3)
not only interact with mRNAs and modulate their
post-transcriptional fate, but are also capable of interact-
ing with DNA (19,20).
Nucleolin is another multifunctional protein capable of
interacting with DNA and RNA. With an apparent mo-
lecular weight of 100kDa and a length of 710 amino acids,
nucleolin has several different domains: an N-terminal
segment with multiple phosphorylation sites, a central
domain with four RNA-recognition motifs (RRMs) and
a C-terminal arginine–glycine-rich (RGG) domain
(21–24). Among its functions associated with binding
DNA, nucleolin can induce chromatin decondensation
by the remodeling complex SWI/SNF (switch/sucrose
non-fermentable in yeast), facilitates transcription and
modulates DNA replication (23,25,26). However,
nucleolin is a prominent RBP with a strong presence in
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(r)RNA and is essential for rRNA biogenesis and rRNA
transport to the cytoplasm (21,27–29). Accordingly,
downregulation of nucleolin caused nucleolar disruption
and defects in cell cycle progression and centrosome du-
plication (30). Nucleolin was also found on the plasma
membrane, where it functions in signal transduction,
wound repair and viral infection (31–34); it also affects
other aspects of viral RNA metabolism, including the
translation and replication of viral RNAs (35,36).
The remainder of nucleolin is found in the nucleoplasm
and the cytoplasm, where it is increasingly recognized as a
pivotal regulator of mature mammalian mRNAs
(22,23,37–40). However, its inﬂuence on target mRNAs
differs depending on the target transcript and the experi-
mental system. Nucleolin was reported to interact with the
30-untranslated region (UTR) of numerous mRNAs,
enhancing their stability, as shown for mRNAs encoding
b-globin, amyloid precursor protein (APP), gastrin, B-cell
leukemia/lymphoma 2 (Bcl-2), Bcl-xL, interleukin 2 (IL-2)
and the growth arrest- and DNA damage-inducible 45
(Gadd45a) (38,40–44). On the other hand, nucleolin inter-
acted with the 50-UTR of the TP53 mRNA and inhibited
p53 translation following DNA damage (45) and with the
50-UTR of prostaglandin endoperoxide H synthase-1
(PGHS1) mRNA, also leading to the repression of
PGHS-1 translation (46). In addition, nucleolin associated
with the 30-UTR of MMP9 mRNA and promoted MMP9
translation (47), and with the 30-UTR of several
selenoprotein mRNAs, similarly promoting their transla-
tion (48).
Here, we sought to identify systematically the collec-
tion of mammalian nucleolin target mRNAs.
Immunoprecipitation (IP) of nucleolin ribonucleoprotein
(RNP) complexes was followed by microarray analysis to
elucidate target mRNAs. These targets encoded proteins
involved in several key cellular processes such as transla-
tion, viral infection, metabolism, carcinogenesis and cell
proliferation. Computational analysis of the target RNAs
revealed a G-rich signature sequence present in the coding
regions (CRs), and the 50- and 30-UTRs of a majority of
target mRNAs. In vitro binding assays conﬁrmed that
both endogenous nucleolin and recombinant puriﬁed
nucleolin were capable of binding biotinylated transcripts
spanning the 50-UTR, CR and 30-UTR of different targets
analyzed, all of which contained the G-rich signature
motif. Functionally, nucleolin enhanced the translation
of target mRNAs, as assessed by polysome proﬁling,
nascent translation and reporter construct analyses. In
sum, we have identiﬁed a large subset of nucleolin target
mRNAs, found a signature G-rich sequence present in
coding and non-coding regions of these mRNAs and dis-
covered that nucleolin can function as a translation
enhancer for this group of target mRNAs.
MATERIALS AND METHODS
Cell culture and transfection
Human cervical carcinoma HeLa cells were cultured in
DMEM containing 5% fetal bovine serum (FBS)
supplemented with glutamine and antibiotics. For
silencing nucleolin, cells were transfected with either
control (Ctrl) siRNA (Qiagen) or nucleolin (NCL)-
directed siRNA (Santa Cruz). Plasmid pGEX-
4T2-Nuc-C (284–707 amino acids) was used to engineer
a plasmid lacking the RGG domain [pGEX-4T2-Nuc-C
(284—644 amino acids)]; these plasmids were used to
express GST-NCL and GST-NCL(RGG), respectively,
each lacking the N-terminal 283 amino acids that rendered
the proteins insoluble. For reporter analyses, cells were
transfected with pGFP or with the vectors engineered to
express wild type of mutant nucleolin motif hits (M1, M2,
M3), inserted in the CR or 30-UTR: pGFP-M1, pGFP-
M2, pGFP-M3, pGFP-30M1, pGFP-30M2, pGFP-30M3,
pGFP-30M1mut, pGFP-30M2mut and pGFP-30M3mut;
100ng plasmid was used per transfection. All transfections
were carried out using Lipofectamine-2000 (Invitrogen)
following the manufacturer’s protocol.
RNP IP and microarray analysis
Endogenous mRNA–protein complexes were precipitated
as previously described (49). Brieﬂy, HeLa cytoplasmic
lysates were prepared in polysome lysis buffer (PLB)
[100 mM KCl, 5mM MgCl2, 10mM HEPES, pH 7.0,
0.5% Nonidet P-40, 1mM dithiothreitol (DTT)] contain-
ing 100U/ml RNase OUT (Invitrogen) and a protease
inhibitor cocktail (Roche). For microarray analysis,
3mg of lysate were incubated (1h, 4 C) with 100ml of a
50% (v/v) suspension of protein-A Sepharose beads
precoated with 20mg each of mouse anti-nucleolin or
mouse IgG (Santa Cruz). Beads were washed with NT2
buffer (50mM Tris–HCl [pH 7.4], 150mM NaCl, 1mM
MgCl2 and 0.05% NP-40) and then incubated with 100ml
of NT2 buffer containing RNase-free DNase I (20U,
15min, 30 C), washed with NT2 buffer and further
incubated in 100ml NT2 buffer containing 0.1% SDS
and 0.5mg/ml Proteinase K (15min, 55 C) to digest
proteins bound to the beads. RNA was extracted using
phenol and chloroform, precipitated in the presence of
glycoblue (Applied Biosystems) and used for further
analysis.
For Illumina microarray analysis, the RNA obtained
after IP reactions using either anti-nucleolin or IgG
antibodies was assessed using an Agilent 2100 bioanalyzer
and RNA 6000 nanochips. The RNA was used to generate
biotin-labeled cRNA using the Illumina TotalPrep RNA
Ampliﬁcation Kit (Ambion; Austin, TX, USA cat #
IL1791), which was then hybridized to Illumina’s Sentrix
HumanRef-8 Expression BeadChips (Illumina, San
Diego, CA, USA), containing 24000 well-annotated
RefSeq transcripts with  30-fold redundancy. The
arrays were scanned using an Illumina BeadStation
500X Genetic Analysis Systems scanner and the image
data extracted using Illumina BeadStudio software,
version 1.5, normalized by Z-score transformation and
used to calculate differences in signal intensities.
Signiﬁcant values were calculated from three independent
experiments, using a two-tailed Z-test and P<0.01. The
complete list of mRNAs enriched in nucleolin IP identiﬁed
on the arrays is shown in Supplementary Table S1.
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The top 335 human transcripts enriched in nucleolin IP
(Supplementary Table S1) served as the experimental data
set for the computational identiﬁcation of the nucleolin
motif. Transcript sequences (UniGene) were scanned
with RepeatMasker (www.repeatmasker.org) to remove
repetitive sequences, and complete, high-quality sequences
were ﬁrst divided into 100-base-long subsequences with a
50-base overlap between consecutive sequences and were
organized into 50 data sets. Common RNA motifs were
then elucidated from each of the 50 random data sets. The
top 10 candidate motifs from each random data set were
selected and used to build the stochastic context-free
grammar (SCFG) model, which summarizes the folding,
pairing and additional secondary structure features. The
SCFG model of each candidate motif was then used to
search against the experimental data set as well as the
entire human UniGene data set (50-UTR, CR, 30-UTR)
to obtain the hits. The motif with the highest enrichment
in the experimental dataset compared with the entire
UniGene dataset was considered to be the top nucleolin
candidate motif. The identiﬁed RNA motif for nucleolin
forms a stem loop. The identiﬁcation of the RNA motif in
unaligned sequences was conducted using FOLDALIGN
software and the identiﬁed motif was modeled by the
SCFG algorithm and searched against the transcript
data set using the COVE and COVELS software
packages (50,51). The motif logo was constructed using
WebLogo (http://weblogo.berkeley.edu/). RNAplot was
used to depict the secondary structure of the representa-
tive RNA motifs. The computation was performed using
the NIH Biowulf computer farm. Both UniGene and
RefSeq datasets were downloaded from NCBI.
RNA isolation and RT–qPCR analysis
Total RNA was isolated from cells using Trizol
(Invitrogen) from intact cells or from RNP IP samples
and was used to measure gene expression or to validate
microarrays, respectively. After reverse transcription (RT)
using random hexamers and SSII reverse transcriptase
(Invitrogen), real-time, quantitative (q)PCR analysis was
performed using gene-speciﬁc primer pairs (below) and
SYBR Green PCR master mix (Kapa Biosystems). The
oligomer pairs (each forward and reverse) used for the
ampliﬁcation of PCR products were as follows: AGGCC
CTTTTGGATCTTCAT and CAGGTGGTCACCCATC
TTCT for FTL, AGCGGAAGGAGGAGAAAAAG and
GTACTCTTGGGCAGGTGAGC for EEF1G, ATCTTC
AAGTGGGTGCCAGT and AGATCCAGCAGGATG
AGAGG for BCL7C, GAGATGGTGTCTGGGAGC
AT and CTGGGTGTGGTCCATCTCTT for STX10,C
ACCCAAACACAAGGTCTCA and GGGGCAGAGA
ACATCACATT for CTAG2, GACGCCATTGACCTG
AACTT and GCACGTGACAGGAACAGAGA for
DUS1L, TGGGTGGAGGACTACTGAGG and CAGT
CCAGAGTCCAACAGCA for STUB1, CAAGACGGG
AGCGAGTAAAG and GGCCTCTTTGAAGGTCTC
CT for USF2, TGAAGCCATCAACTCACAGC and C
TGGCAGAACTGCTTGAACA for MAF1, GCTGCA
GGAGTCTGTCATCA and AGTGGGGTACGAATG
GAGGT for METRN, ATTCTAACTCGCCTGCCA
GA and CTATGAGGCTGGGCATCTGT for GLOT1,
CCCAGAGTTCCTCTGAGCAC and CTTCAGCGTT
ATGCCTGTCA for AGBL5, TACGCCAAGAAGCTG
AGACA and TCTGGGAAGAGTGAGCAGGT for
PGLS, TCTATGGCGCTGAGATTGTG and CTTAAT
GTGCCCGTCCTTGT for AKT1, CCCCAGAAACAG
GAGAATCA and TATGCTTTGTGGCATCTGGA for
PDCD2, AGAGCCAAGCTGCACAATTT and AGCCA
GACAGGAAGAGACCA for NBL1, GCTGGCCAAA
CTCAAGTACC and TTTTGGATGAGCCTTTACGG
for CCNI, ATATGCCTTCCCCCACTACC and CGTG
AGTGCTCACTCCAGAA for CDKN2A, TAGTTGAC
AATCGGGGCTTC and GGGTCAGCTGCAGTTTAA
GG for MKNK2, TGTGCAGAGAGTTTGGCAAC and
GGGAAGGGGAGCAGGTATAG for MGAT1, TGCA
ACAACCAGAAAAGCTG and TCTCGAAGATGCAC
AGGTTG for LRP3, CTTTGTCAGCCAAGGAAAGC
and GCTCACTGGGCACTTTTCTC for MG21, GTCC
AGGACACCTCCAAGAA and TATGCCAAACCCAT
CTCCTC for AP1S1, and TGCACCACCAACTGCTTA
GC and GGCATGGACTGTGGTCATGAG for
GAPDH.
Assessment of translation by polysomal mRNA analysis
and
35S labeling
HeLa cells were transfected with siRNA and 48h later
cells were incubated with 0.1mg/ml cycloheximide for
10min. Cytoplasmic extracts (1mg each) were prepared
and fractionated through linear sucrose gradients
[10–50% (w/v)], as previously reported (52). Twelve frac-
tions were collected using a fraction collector (Brandel)
and monitored by optical density measurement (A254).
The RNA in each fraction was isolated using Trizol
(Invitrogen). Following RT, qPCR analysis was per-
formed using speciﬁc primer pairs; primer sequences are
shown above. To assess the levels of nascent translation,
de novo synthesis of Usf2, Akt1, Flot1 and GAPDH was




TMEXPRESS; NEN/Perkin Elmer, Boston, MA). Cells
were lysed in RIPA buffer (10 mM Tris-HCl [pH 7.4],
150mM NaCl, 1% NP-40, 1mM EDTA, 0.1% SDS,
and 1mM dithiothreitol), and the IP reactions were
carried out in 1ml TNN buffer (50mM Tris-HCl [pH
7.5], 250mM NaCl, 5mM EDTA, 0.5% NP-40) for 16h
at 4 C, using anti- IgG, Usf2, Akt1, Flot1 and GAPDH
antibodies (Santa Cruz Biotechnology). After IP samples
were washed extensively in TNN buffer, the samples were
resolved by SDS-PAGE, transferred onto polyvinylidene
diﬂuoride membrane ﬁlters, and visualized with a
PhosphorImager (Molecular Dynamics).
Western blot and biotin pull-down analyses
Whole-cell lysates were prepared with RIPA buffer
[10 mM Tris–HCl (pH 7.4), 150mM NaCl, 1% NP-40,
1mM EDTA, 0.1% SDS and 1mM dithiothreitol].
Proteins were resolved by SDS–polyacrylamide gel elec-
trophoresis and transferred to polyvinylidene diﬂuoride
membranes (Invitrogen). After incubation with primary
Nucleic Acids Research, 2011,Vol.39, No. 19 8515antibodies recognizing nucleolin, Flot1, Usf2, Akt1, GFP
or a-tubulin (Santa Cruz), or recognizing b-actin
(Abcam), membranes were incubated with the appropriate
secondary antibodies and signals were detected by ECL
Plus (Amersham).
For biotin pull-down assays, PCR fragments containing
the T7 RNA polymerase promoter sequence [(T7), CCAA
GCTTCTAATACGACTCACTATAGGGAGA] were
used as templates for in vitro transcription. Biotinylated
transcripts were incubated with cytoplasmic lysates
(100mg lysate, 3mg biotinylated RNA) or with recombin-
ant puriﬁed protein [GST, GST-NCL or GST-
NCL(RGG), 1mg protein and 2mg biotinylated RNA
per reaction] for 30min at room temperature, and
complexes were isolated with streptavidin-coated
magnetic Dynabeads (Dynal) and analyzed using
western blot analysis to detect nucleolin or GST-NCL.
The following primer pairs (forward and reverse, respect-
ively) were used:
(T7)CCCGCGAGCGGACGCG and GATATCCTTTG
GATCTGCCTGCTAC for CCNI 50,
(T7)ATGAAGTTTCCAGGGCCTTT and AATTGCAG
AAGTTGGTTGCAG for CCNI CR1,
(T7)AACTACTTCACTGTATGGCC and CTACATGA
CAGAAACAGGCT for CCNI CR2,
(T7)TTTCAACAAGTGCTACCTTTGAG and GGTCT
TTATGTGCTTAAATAACGC for CCNI 30,
(T7)CGGCAGGACCGAGCG and GGTGCCCGAGG
CTCCCG for AKT1 50,
(T7)ATGAGCGACGTGGCTATTG and TCGGAGAA
CACACGCTCC for AKT1 CR1,
(T7)AGCTGTTCTTCCACCTGTCC and TCAGGCCG
TGCCGCTG for AKT1 CR2,
(T7)GGCGGCGGTGGACTG and CTGGGGGGCTG
CTGTG for AKT1 301,
(T7)ACCCTCTCCTGGGGG and GAAAAGCAACTT
TTATTGAAGAATTT for AKT1 302,
(T7)ACCCTCTCCTGGGGG and GGTTCAGGCTGG
AGCTTCC for FLOT1 50,
(T7)ATGTTTTTCACTTGTGGCCC and CTTCTTCA
GTTCGTAATCTCT for FLOT1 CR1,
(T7)CGAGATGGCCAAGGCACA and TCAGGCTGT
TCTCAAAGGCT for FLOT1 CR2, and
(T7)GCCTTCAGCCCTCACAG and AGTACTTACTT
ACAGCAATTTATTTG for FLOT 30.
The predicted nucleolin binding motifs were synthesized
from longer complementary oligomer pairs containing the
T7 polymerase promoter sequence. Complementary oligo-
mers were annealed and used as template for in vitro tran-
scription using biotin-conjugated cytidine triphosphate
(CTP). After isolating the biotinylated transcripts,
binding assays with whole-cell lysate (using 3mg
biotinylated RNA) or GST fusion proteins (1mg
biotinylated RNA) were done as described above. The
oligomer pairs were as follows:
(T7)GAGGAAGGGAGGGGCTGGGGGCTACGCCC
CCTCC and GGAGGGGGCGTAGCCCCCAGCC
CCTCCCTTCC for BRD2 50-UTR1,
(T7)AGATGTGGCGGGTTGCCACTTCCCTGTGGG
TCTCT and AGAGACCCACAGGGAAGTGGCA
ACCCGCCACATCT for BRD2 50-UTR2,
(T7)CCCTGGGGAAGGGAATGCAGGGTTGCTGG
GGCTGG and CCAGCCCCAGCAACCCTGCAT
TCCCTTCCCCAGGG for BRD2 CR,
(T7)CGTGGGCGTGGCCGGCGTGGCTGCTCGGG
ACCA and TGGTCCCGAGCAGCCACGCCGGC
CACGCCCACG for PEX10 50-UTR,
(T7)AGGAGGGCGCTGCTGCGGGCGGTCTTCGTC
CTCA and TGAGGACGAAGACCGCCCGCAGC
AGCGCCCTCCT for PEX10 CR,
(T7)CTCTGGGGGCCGTGGGGTGGGAGCTGGGG
CGAG and CTCGCCCCAGCTCCCACCCCACG
GCCCCCAGAG for BCL2 50-UTR,
(T7)GGGTGTGGCTGGGCCTGTCACCCTGGGGCC
CTCC and GGAGGGCCCCAGGGTGACAGGCC
CAGCCACACCC for BCL2 30-UTR,
(T7)GCCTGGCCCCGAGCCCCGAGCGGGCGTCGC
TCA and TGAGCGACGCCCGCTCGGGGCTCG
GGGCCAGGC for PKD1 50-UTR,
(T7)TGCTGGGCCTGGCTCCCTGGCTGGCCAGCC
TCT and AGAGGCTGGCCAGCCAGGGAGCCA
GGCCCAGCA for PDK1 CR1,
(T7)GCCTGGGCGCGGTGGCTGCTGGTGGCG
CTGA and TCAGCGCCACCAGCAGCCACCGC
GCCCAGGC for PDK1 CR2,
(T7)GGCCGGGCCGGGGGCGGGGGGGCCGGGG
CCCG and CGGGCCCCGGCCCCCCCGCCCCC
GGCCCGGCC for ZNF219 50-UTR,
(T7)AGGCGAGGCCGGGCCTGGGGGTGCCCTCC
ACCG and CGGTGGAGGGCACCCCCAGGCCC
GGCCTCGCCT for ZNF219 CR,
(T7)GCTCGGGCCCGGGCCCGGGCCCCGCAGGCC
TGC and GCAGGCCTGCGGGGCCCGGGCCCG
GGCCCGAGC for FOXD2 CR,
(T7)GTCTGGGCCAGGGACTGGAGAGGTGGGGG
TGGA and TCCACCCCCACCTCTCCAGTCCCT
GGCCCAGAC for FOXD2 30-UTR,
(T7)GGATGGGGATGGGGACTTTGGGGCCGGGG
TCAA and TTGACCCCGGCCCCAAAGTCCCCA
TCCCCATCC for MMP15 CR, and
(T7)GGCTTGGCCACAGCCAGGGGAGCAGAGGG
GCA and TGCCCCTCTGCTCCCCTGGCTGTGG
CCAAGCC for MMP15 30-UTR.
RESULTS
Identiﬁcation of nucleolin target mRNAs
HeLa cells were used to isolate nucleolin-mRNA RNP
complexes using a speciﬁc antibody against nucleolin,
while parallel control IP reactions were performed using
IgG (Figure 1A). The visualization of proteins present in
the anti-nucleolin IP was performed by silver stain
(Figure 1B), revealing a major nucleolin band and
several minor polypeptides that copuriﬁed with nucleolin
(asterisks), and by immunoblot detection of nucleolin
(Figure 1C). The IP reactions were carried out using con-
ditions that preserved protein–mRNA complexes as
8516 Nucleic Acids Research, 2011,Vol.39, No. 19Figure 1. Identiﬁcation of nucleolin target mRNAs by RNP IP and microarray analysis. (A) IP assay using 3mg of protein lysate prepared from
HeLa cells and 20mg of either anti-nucleolin antibody or IgG under conditions that preserved mRNP complexes. (B) Visualization of proteins
present in the anti-nucleolin or IgG IP reactions, including nucleolin (arrowhead) and several unidentiﬁed proteins (asterisks). (C) Nucleolin was
detected by western blot analysis in aliquots of IP samples. (D) Partial list of nucleolin target genes identiﬁed by microarray analysis. The threshold
considered was  2-fold. For a complete list, see Supplementary Table S1. (E) Nucleolin target mRNAs were analyzed using Ingenuity Pathway
Analysis (IPA). The top target transcripts are involved in cancer, infection, cell growth and proliferation. In (B and D), ‘MW’, molecular weight
markers (kDa).
Nucleic Acids Research, 2011,Vol.39, No. 19 8517described (19). The RNA in nucleolin IP and control IgG
IP samples was isolated and analyzed using Illumina
microarrays (‘Materials and Methods’ section). A partial
list of nucleolin target transcripts that were highly
enriched in nucleolin IP relative to IgG IP is shown
(Figure 1D); see Supplementary Table S1 for a complete
list of nucleolin target mRNAs on arrays. Given that
nucleolin was shown to interact with RBPs such as
hnRNP K (43), we studied if other hnRNPs were
detected in nucleolin IP samples. As shown in the
Supplementary Figure S1, there was weak interaction of
hnRNP K with nucleolin, but neither hnRNP D (also
known as AUF1) nor hnRNP C1/C2 were detected in
the nucleolin IP samples. Furthermore, the interaction of
hnRNP K and nucleolin did not appear to inﬂuence the
association of nucleolin with target mRNAs, since these
transcripts generally showed comparable enrichments in
nucleolin IP samples regardless of hnRNP K abundance
(Supplementary Figure S2).
A comparative analysis of nucleolin target mRNAs
using Ingenuity Pathways Analysis (IPA) enabled a
global view of the involvements of these genes in biologic-
al processes. For example, a large number of nucleolin
target mRNAs encoded proteins that were involved in
cancer, genetic disorders and cellular growth, proliferation
and infection; a lesser number of transcripts encoded
proteins involved in other processes such as such as
cell division, DNA replication, recombination and
repair (Figure 1E). A complete list of functional
analysis is provided Supplementary Table S2. These
data indicate that the proteins codiﬁed by nucleolin
target mRNAs are involved in important cellular
processes.
Validation of endogenous and recombinant nucleolin
target transcripts
A subset of nucleolin target mRNAs (Figure 1D) was
validated by RT–qPCR analysis employing gene-speciﬁc
primer pairs, as described (19). Transcripts such as
BCL7C, syntaxin 10 (STX10), STIP1 homology and
U-box containing protein 1 (STUB1), cyclin I (CCNI),
AKT1, ﬂotillin 1 (FLOT1) and upstream transcription
factor 2c-fos (USF2) mRNAs were highly enriched in
nucleolin IP compared to IgG IP samples, as measured
by RT–qPCR (Figure 2) analysis. Binding of nucleolin
to GAPDH mRNA, which encodes a housekeeping
protein, was used for normalization, since GAPDH
mRNA was not a target of nucleolin. Since GAPDH
mRNA is highly abundant, it bound non-speciﬁcally to
IP components (including beads, antibody and reaction
tube) and assessment of GAPDH qPCR product helped
to monitor that sample input was even. As shown,
nucleolin target transcripts were more abundant in
nucleolin (NCL) IP compared with IgG IP.
Binding was also conﬁrmed by using biotinylated tran-
scripts which spanned the 30-UTR, CR and 50-UTR of
target mRNAs (Figure 3 and Supplementary Figure S3).
Biotinylated RNAs were incubated with HeLa cytoplas-
mic lysates, biotinylated RNA–protein complexes were
pulled down using streptavidin-coated beads and the
presence of nucleolin in the RNPs was examined by
western blot analysis (‘Materials and Methods’ section).
Unexpectedly, binding assays using biotinylated tran-
scripts that spanned the entire length of AKT1, FLOT1
and CCNI mRNAs showed that nucleolin associated with
the CR of these transcripts, with the 30-UTR of AKT1
mRNA (but much less with the 30-UTRs of CCNI or
Figure 2. Validation of nucleolin targets by RT–qPCR. The abundance of transcripts present in material obtained from HeLa cells after either
nucleolin IP or IgG IP was assessed by RT–qPCR analysis. Values show the mean enrichment+standard deviation (SD) from three independent
experiments. Measurement of GAPDH mRNA served as loading and background control, since the highly abundant transcript (not a target of
nucleolin) is a detectable contaminant present in the IP reactions.
8518 Nucleic Acids Research, 2011,Vol.39, No. 19FLOT1 mRNAs) and with the 50-UTR of FLOT1 and
CCNI mRNAs (and only weakly with the 50-UTR of
AKT1 mRNA; Figure 3). The biotinylated GAPDH
30-UTR, included as a negative control, did not show
binding to nucleolin (Figure 3C).
Further evidence of the direct interaction of nucleolin
with these RNAs was obtained using recombinant puriﬁed
proteins. Two fusion proteins were prepared (each lacking
the acidic N-terminal domain that renders nucleolin insol-
uble): GST-NCL and GST-NCL(RGG), the latter
lacking the RGG domain through which nucleolin can
associate with other molecules, including RNA
(Figure 4A). Incubation of both GST fusion proteins
with the partial biotinylated transcripts (Figure 3)
revealed an association of GST-NCL with the biotinylated
CCNI and AKT1 RNAs tested (Figure 4B and C) and
with the CR segments of FLOT1 RNA. On the other
hand, GST-NCL(RGG) interacted with some fragments
of CCNI and AKT1 mRNAs, but less overall than
GST-NCL, but not with FLOT1 RNAs. GST alone did
Figure 3. Biotin pull-down assays to assess nucleolin binding to biotinylated transcripts. The indicated biotinylated transcripts (heavy bars) were
incubated with cytoplasmic protein lysate from HeLa cells, whereupon their association with nucleolin was detected by western blot analysis. The
interaction of nucleolin with biotinylated transcripts spanning different regions of CCNI (A), AKT1 (B) and FLOT1 (C) mRNAs was studied by
biotin pull-down analysis (‘Materials and Methods’ section).
Nucleic Acids Research, 2011,Vol.39, No. 19 8519not interact with these biotinylated RNAs (data not
shown), nor did it interact with shorter nucleolin target
mRNAs (see Figure 6 below). Although the patterns of
association of the biotinylated RNAs with endogenous
nucleolin were often similar to those seen with
GST-NCL, they were not identical. These discrepancies
are likely due to the fact that endogenous nucleolin asso-
ciates with the biotinylated RNAs in competition (or
perhaps in cooperation) with other RBPs and other mol-
ecules present in the lysate. Therefore, the net binding of
endogenous nucleolin and biotinylated RNAs reﬂects the
combined inﬂuence of other surrounding factors. In
contrast, when the biotinylated RNA is incubated with
GST-NCL, there are no competing or cooperating RBPs
or other molecules in the binding reaction, so the pattern
of binding can differ from that seen with the endogenous
nucleolin. Taken together, the data in Figures 3 and 4
indicate that both endogenous and recombinant nucleolin
can associate with cellular target mRNAs and with in vitro
synthesized partial transcripts. They also suggest that the
four RNA-binding domains of nucleolin cooperate with
the RGG domain to enhance these interactions.
Transcriptome-wide identiﬁcation and validation of a
G-rich nucleolin binding motif
Since nucleolin exhibited afﬁnity for different mRNA
regions besides the 30-UTR (Figures 3 and 4), we did not
restrict our search for nucleolin signature motifs among
target mRNAs to the 30-UTRs but included CRs and
50-UTRs. Nucleolin target mRNAs were used in compu-
tational analyses to identify common RNA signature
motifs based on shared primary RNA sequences and
Figure 4. In vitro interaction of recombinant nucleolin with biotinylated transcripts. (A) Schematic of nucleolin, with its central four
RNA-recognition motifs (RRMs, dark gray) and its RGG domain (hatched), and plasmids pGST-NCL and pGST-NCL(RGG) used to purify
GST-NCL and GST-NCL(RGG), respectively. (B–D) The biotinylated RNAs used in Figure 3 were incubated with either GST-NCL or
GST-NCL(RGG) proteins (‘Materials and Methods’ section); after binding to partial CCNI RNAs (B), AKT1 RNAs (C) and FLOT1 RNAs
(D), as well as with the negative control GAPDH RNA, the fusion proteins were detected by western blot analysis using an anti-nucleolin antibody.
8520 Nucleic Acids Research, 2011,Vol.39, No. 19secondary structures (‘Materials and Methods’ section).
The resulting motif logo (relative frequency of nucleo-
tides) was highly enriched in G residues (Figure 5A).
The sequences of eight speciﬁc motif hits and their second-
ary structures are shown in Figure 5B and C.
Using the entire UniGene database, the G-rich
nucleolin motif was found to be abundant within the
CR and both UTRs (Figure 5D); in fact, its frequency
was comparable among the lists of motif predictions in
the 50-UTR, CR and 30-UTR (Figure 5E; complete lists
are available in Supplementary Tables S3–S5). Four
mRNAs that were predicted to be nucleolin target
mRNAs based on the presence of the G-rich motif (the
MGAT1, MG21, LRP3 and AP1S1 mRNAs) were tested
using RT–qPCR and speciﬁc primer pairs. All four were
enriched in nucleolin IP (Figure 5F), indicating that the
G-rich motif has good predictive value for identifying
nucleolin target mRNAs.
Next, we tested the ability of nucleolin to bind to the
speciﬁc RNA motif hits in several mRNAs. Short
biotinylated RNAs comprising the sequences shown
were tested by biotin pull-down assay using HeLa cyto-
plasmic lysates (Figure 6A). Nucleolin was found to bind
the short RNA motifs from different regions (50-UTR, CR
and 30-UTR). For the FOXD2 mRNA, nucleolin appeared
to bind the CR motif more strongly than the 30-UTR
motif. Nucleolin bound to motif CR1 (but not to motifs
CR2 or 50-UTR) of the PDK1 mRNA and also interacted
with hits in the 50-UTR and the CR of BRD2 and PEX10
mRNAs, as well as with hits in the 30-UTR and 50-UTR of
BCL2 mRNA. All the hits tested within the ZNF219 and
MMP15 mRNAs also associated positively with nucleolin.
The intensity of these interactions varied among the tran-
scripts (Figure 3); biotinylated GAPDH RNA segments
did not show interaction in this assay (data not shown).
These short biotinylated RNAs also showed strong in vitro
interaction with recombinant puriﬁed GST-NCL, but less
with GST-NCL(RGG), as observed with longer
biotinylated RNA (Figure 4); there was no interaction of
biotinylated RNA with GST (Figure 6B). Together, these
data indicate that nucleolin is able to bind G-rich motif
elements within the 30-UTR, CR and 50-UTR and that the
RGG domain likely cooperates with the RRMs to form
these interactions.
Nucleolin promotes mRNA translation without
inﬂuencing mRNA stability
Many RBPs which associate with mature mRNAs often
regulate their stability and/or translation. To investigate
the functional inﬂuence of nucleolin upon target mRNAs
bearing the G-rich motif, we speciﬁcally silenced nucleolin
using small interfering (si)RNA directed to the nucleolin
mRNA. Downregulation of nucleolin did not inﬂuence
the steady-state levels of most of the mRNAs tested
(Figure 7A), nor did it change the half-lives of these
mRNAs, as measured by RT–qPCR after treatment with
actinomycin D (Supplementary Figure S4 and data not
shown). Thus, for mRNAs whose levels declined moder-
ately after nucleolin silencing (including AKT1, MAF1
and CCNI), it is likely that nucleolin affects the levels of
transcription factors or other proteins that modulate their
transcriptional expression. Testing of a subset of nucleolin
targets (those encoding Flot1, Usf2, Dus1l, Akt1 or
Cyclin I) following nucleolin silencing revealed a greater
magnitude of reduction in protein level (Figure 7B) than
was seen at the mRNA level (Figure 7A). As previously
reported, nucleolin silencing increased the abundance of
p53 and reduced the abundance of Bcl-2, included here as
positive controls (Figure 7C). Among the reported
nucleolin targets, the mRNAs encoding APP, Bcl-2, p53,
PGHS1 and several selenoproteins were found to have hits
in the 30-UTR; BCL2 and PGHS1 mRNAs had coding
region hits; and one selenoprotein (SEP15) mRNA had
hits in the 50-UTR (Supplementary Tables S3–S5).
Since nucleolin downregulation did not affect markedly
the steady-state levels of most target mRNAs (Figure 7A),
we investigated whether mRNA translation was altered by
studying the sizes of polysomes associated with nucleolin
target mRNAs (‘Materials and Methods’ section).
Nucleolin downregulation did not alter the global
proﬁles of polysomes in cells transfected with control or
nucleolin-directed siRNAs, as observed by comparing the
relative levels of free mRNAs (-), small (40S) and large
(60S) ribosomal subunits, monosomes (80S) and low- and
high-molecular weight polysomes (LMWP, HMWP,
respectively) (Figure 8A). Although nucleolin promotes
polysome biogenesis and cell cycle progression, there
was no global inhibition of protein synthesis by 48h
after silencing nucleolin (Supplementary Figure S5).
However, when individual mRNAs present in the different
polysome gradient fractions were compared between Ctrl
siRNA and NCL siRNA populations, MGA1, AKT1,
FLOT1, LRP3, MG21 and CCNI mRNAs were all
found in relatively lighter polysomal fractions after
silencing nucleolin; this was manifested as leftward shifts
in the distribution peaks, indicative of smaller polysomes.
For example, FLOT1 mRNA was most abundant in poly-
somes peaking at fraction 9 in control cells, but the peak
was in fraction 7 in nucleolin-silenced cells; CCNI, LRP3
and AKT1 mRNAs shifted peaks from fraction 8 to
fraction 7 after silencing nucleolin, MG21 mRNA shifted
from a peak in fraction 6 to a peak in fraction 3, and
MGA1 mRNA from fraction 6 to 5 (Figure 8B).
Additional evidence that translation of these proteins
was reduced came from experiments to measure nascent
translation of speciﬁc proteins. Following incubation of
HeLa cells with
35S-Met/Cys for 20min (to faithfully
detect newly synthesized protein and have a negligible
contribution of protein decay), lysates were subjected to
IP reactions in the presence of antibodies recognizing the
proteins in Figure 7B, and the immunoreactive,
35S-labeled proteins were visualized. As shown, the
de novo translation of Usf2, Akt1 and Flot1 was reduced
in nucleolin-silenced cells, while incorporation of label
into a control housekeeping protein (nascent
35S-GAPDH) was equal and overall signals in both lanes
were similar (IgG IP, Figure 8C). Other proteins (e.g.
Cyclin I or Dus1L were not detectable using this
low-efﬁciency de novo translation assay). These results
underscore nucleolin’s function as an enhancer of the
translation of a subset of target mRNAs.
Nucleic Acids Research, 2011,Vol.39, No. 19 8521Figure 5. Sequence, structure and genome-wide predictions of nucleolin binding motif. (A) Probability matrix (graphic logo) depicting the relative
frequency of ﬁnding each residue at each position within the motif, which was elucidated from the microarray data set. (B) Structural alignment
of eight examples of the nucleolin motif in speciﬁc mRNAs (transcript names are indicated). (C) Secondary structure of the nucleolin motifs shown
in (B). (D) Number of nucleolin motif hits identiﬁed transcriptome wide. (E) Frequency of nucleolin hits per 10kb of CR or UTR, transcriptome
wide. (F) Validation of nucleolin binding to four predicted target transcripts (MGAT1, MG21, LRP3 and AP1S1 mRNAs) bearing hits of the G-rich
nucleolin motif identiﬁed in (A).
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To further ascertain if the nucleolin signature motif
elicited its inﬂuence from the CR and the 30-UTR, we
studied the effect of inserting the motif in different sites
of a heterologous reporter construct. A reporter plasmid
expressing GFP (pGFP) was used to generate three
separate constructs bearing motifs M1, M2 and M3
(from AP1S1, LRP3 and MGAT1 mRNAs, respectively)
inserted in frame in the CR before the GFP stop codon
(pGFP-M1, pGFP-M2 and pGFP-M3), three constructs
Figure 6. Biotin pull-down assays to assess binding of nucleolin (endogenous or recombinant) to predicted target motifs. (A) The indicated
biotinylated transcripts were incubated with cytoplasmic protein lysate from HeLa cells; following pull down, their association with nucleolin was
detected by western blot analysis. (B) Recombinant puriﬁed proteins [GST-NCL, GST-NCL(RGG) or GST] were incubated with the biotinylated
transcripts shown; after pull down, their association was detected by western blot analysis using an antinucleolin antibody (‘Materials and Methods’
section).
Nucleic Acids Research, 2011,Vol.39, No. 19 8523Figure 7. Nucleolin promotes gene expression without inﬂuencing target mRNA stability. (A) RT–qPCR analysis of a subset of nucleolin target
mRNAs 2 days after transfecting HeLa cells either with control (Ctrl) siRNA or nucleolin (NCL) siRNA. Data shown are the means and SD from
three independent experiments; GAPDH mRNA was included for normalization. (B and C) Two days after transfecting HeLa cells as explained in
(A), the levels of nucleolin, Flotillin-1, USF2, AKT1, Dus1L and Cyclin I (B), as well as positive controls (encoded by previously reported nucleolin
target mRNAs) p53 and Bcl-2 (C) and loading controls a-tubulin and b-actin were assessed by western blot analysis.
8524 Nucleic Acids Research, 2011,Vol.39, No. 19Figure 8. Nucleolin promotes mRNA translation. (A) Forty-eight hours after transfection of HeLa cells with either Ctrl siRNA or NCL siRNA,
lysates were prepared and fractionated through sucrose gradients into 12 gradient fractions; 40S and 60S, small and large ribosome subunits,
respectively; 80S, monosome; LMWP and HMWP, low- and high-molecular weight polysomes, respectively (‘Materials and Methods’ section).
(B) The relative distribution of nucleolin target mRNAs and housekeeping GAPDH mRNA was studied by RT–qPCR analysis of RNA in each
of fraction. (C) De novo translation of proteins Usf2, Akt1, and Flot1 and housekeeping protein GAPDH (left) was determined in HeLa cells 48h
after transfection with the small RNAs shown; cells were incubated for 20min with
35S-labeled amino acids, whereupon the incorporation of the
radiolabel into each protein was compared with the unchanged incorporation into GAPDH and with the nonspeciﬁc label incorporation detected in
the IgG IP samples (right); details in Materials and Methods. Data are representative of three independent experiments.
Nucleic Acids Research, 2011,Vol.39, No. 19 8525with the same motifs sequences inserted in the 30-UTR,
after the stop codon (pGFP-30M1, pGFP-30M2 and
pGFP-30M3) and three additional constructs with
mutated versions of M1, M2 and M3, in which all Gs
were replaced with Cs (pGFP-30M1mut, pGFP-30M2mut
and pGFP-30M3mut; Figure 9A). Transfection of these
plasmids into HeLa cells that expressed either normal or
reduced levels of nucleolin was followed by western blot
analysis to assess GFP expression. As shown in Figure 9B,
nucleolin silencing strongly reduced GFP expression of all
constructs bearing nucleolin motifs in 30-UTR. When
nucleolin motifs were inserted in the CR of the reporter
construct, GFP expression was variable: after silencing
nucleolin, GFP expressed from pGFP-M1 remained
elevated, GFP expressed from pGFP-M2 was moderately
downregulated and GFP expressed from pGFP-M3 was
markedly reduced (Figure 9B). All the mutant reporters
were refractory to nucleolin silencing. GFP mRNA levels
in these transfection groups remained unchanged by
nucleolin silencing (Supplementary Figure S6). Together,
these ﬁndings indicate that the presence of the nucleolin
signature motif in the 30-UTR of target mRNAs strongly
enhances translation by nucleolin, while its presence in the
CR has a less robust inﬂuence.
DISCUSSION
We report the global identiﬁcation of nucleolin target
mRNAs. These mRNAs encoded proteins involved in
key mammalian processes such as cell proliferation, viral
infection and carcinogenesis. Computational analysis of
the target mRNAs revealed the presence of a consensus
G-rich RNA signature motif that was detected in all
regions of the mRNA—50-UTR, CR and 30-UTR.
Nucleolin exhibited an afﬁnity for RNAs bearing the
G-rich signature motif, both endogenous mRNAs and re-
combinant biotinylated RNAs assessed in vitro. Similarly,
recombinant puriﬁed nucleolin (GST-NCL) associated
in vitro with these biotinylated RNA targets, indicating
that nucleolin was capable of interacting with these
mRNAs in the absence of other proteins. Nucleolin did
not globally inﬂuence the stability of target mRNAs
bearing the G-rich motif, but instead enhanced target
mRNA translation. Nucleolin’s preference for G-rich
elements adds to an expanding repertoire of turnover-
and translation-regulatory mRNA sequences, which now
includes motifs such as those rich in AU, U, CA, GU and
CU (53).
Translational regulation vs mRNA turnover
The ﬁnding that nucleolin broadly enhanced the transla-
tion of this subset of target mRNAs was unexpected.
Nucleolin was previously reported to increase the stability
of some target mRNAs. For example, nucleolin associated
with AU-rich elements in the BCLXL 30-UTR, enhancing
BCLXL mRNA stability and Bcl-xL protein levels in
human keratinocytes following irradiation with ultraviolet
light (UVA) and it also enhanced the stability of BCL2
mRNA (39,54). Treatment with the nucleolin-directed
aptamer AS1411 (presently in clinical trials, phase II)
was recently found to inhibit nucleolin binding to BCL2
mRNA, in turn increasing the association of BCL2
mRNA with AUF1, an RBP that can destabilize some
target mRNAs (55,56). Thus, at least for BCL2 mRNA,
nucleolin can stabilize a target mRNA by competing with
AUF1; perhaps similar competition paradigms explain the
effect of nucleolin in the stabilization of other ligand
RNAs. It is interesting to note that the nucleolin-targeted
aptamer AS1411 is a G-rich oligodeoxynucleotide (26-nt
long) (55,57), supporting the notion that nucleolin indeed
has afﬁnity to G-rich sequences.
Nucleolin and hnRNP E interacted with the 30UTR of
human b-globin mRNA and enhanced its half-life (41),
and nucleolin, hnRNP K and PCBP1 associated with
and stabilized gastrin mRNA in human gastric adenocar-
cinoma cells (43). Whether nucleolin competed with
binding of decay-promoting RBPs in these instances was
not reported. On the other hand, some RBPs that inﬂu-
ence mRNA stability and translation (e.g. HuR, NF90,
TTP, BRF1 and KSRP) have afﬁnity for U/AU-rich se-
quences in the 30-UTR of target transcripts (8,12,40,58–
61). The fact that nucleolin can bind to G-rich sequences
suggests that it may not always compete with other RBPs,
and may instead cooperate with or recruit other RBPs to
shared mRNA targets. The speciﬁc functional interactions
of nucleolin and other RBPs (as well as non-coding
RNAs) warrant future study.
As mentioned above, nucleolin was also reported to
modulate the translation of a handful of mRNAs. Both
nucleolin and the ribosomal protein L26 (RPL26) bound
the 50-UTR of TP53 mRNA and controlled p53 transla-
tion in breast carcinoma cells, RPL26 enhanced it, while
nucleolin suppressed it (45). Similarly, nucleolin interacted
with the 50-UTR of PGHS1 mRNA and repressed
PGHS-1 production (46). In contrast, nucleolin binding
to the 30-UTR of MMP9 mRNA enhanced MMP9 trans-
lation in human ﬁbrosarcoma HT1080 cells treated with
2,2-dipyridyl (2,2-DP) (47). Hypoxia treatment of HT1080
cells also increased expression of C-P4H-a(I) (collagen
prolyl 4-hydroxylase) mediated by a  64-kDa cleavage
product of nucleolin which bound to the C-P4H- (I)
50-UTR (62). Similarly, nucleolin associated with the
30-UTR of several selenoprotein mRNAs and promoted
mRNA translation (48). Whether nucleolin represses
translation through the 50-UTR but enhances it through
the 30UTR should also be examined systematically.
Controlling gene expression from the CR
Although traditionally the CR has not been reported to
harbor many stability/translation regulatory elements, it is
now clear that much of the cellular mRNA is not bound to
ribosomes, including nuclear mRNAs and cytoplasmic
mRNAs being transported or in storage (63). Other
mRNAs are occupied sparsely by ribosomes (64,65),
indicating that a large pool of untranslated mRNA and
CR mRNA segments are available for interaction with
RBPs like nucleolin and with non-coding RNAs. It will
be important to study systematically the association of
nucleolin with nuclear and cytoplasmic mRNAs.
Whether cytoplasmic nucleolin interacts with the CR of
8526 Nucleic Acids Research, 2011,Vol.39, No. 19Figure 9. Reporter construct analysis to validate the nucleolin RNA motif. (A) Schematic representation of three nucleolin motif hits (M1, M2, M3)
and the G-to-C mutant motifs (M1mut, M2mut and M3mut) cloned in the 30-UTR or the CR of pGFP reporter constructs. (B) Left, 48h after
cotransfection of these constructs either with Ctrl or NCL siRNAs, cells were lysed and western blot analysis was performed to assess the levels of
GFP, nucleolin and loading control b-actin; right, GFP levels were quantiﬁed by densitometry and plotted. Transfection with NCL siRNA reduced
nucleolin levels to  21% (pGFP group), 28–46% (pGFP-M1, -M2, -M3 group), 26–34% (pGFP-30M1, -30M2, -30M3 group), 32–39%
(pGFP-30M1mut, -30M2mut and 30M3mut group).
Nucleic Acids Research, 2011,Vol.39, No. 19 8527mRNAs devoid of ribosomes, with lightly translated
mRNAs (mRNAs forming low-molecular weight poly-
somes), or with mRNAs localized in the plasma
membrane also deserves further study.
Nucleolin binding under basal and stress-stimulated
conditions
The association of nucleolin with mRNAs bearing G-rich
motifs, and the ensuing translational upregulation, may
only occur in unstimulated conditions such as those
studied here. Exposure to growth factors, mitogens, stres-
sors or other stimuli could alter nucleolin’s afﬁnity for
mRNAs, allowing it to bind different sequences and
possibly affecting other post-transcriptional processes,
like mRNA turnover. For example, treatment with EGF
increased nucleolin binding to gastrin mRNA and
enhanced its interaction with hnRNP K; these events
were linked to changes in gastrin mRNA half-life (43).
It is also worth noting that nucleolin was identiﬁed as a
genotoxic stress-responsive RBP, whose levels, localiza-
tion and interaction with other RBPs were inﬂuenced by
UV irradiation and other stresses (66,67). In this regard,
nucleolin is post-translationally modiﬁed by phosphoryl-
ation [via casein kinase II (CKII), protein kinase C (PKC)
and cell division cycle kinase 2 (CDC2) (68–70)], by
methylation and by ADP-ribosylation (21,30). Further
studies are needed to understand in detail how these modi-
ﬁcations affect nucleolin function. Phosphorylation and
other post-translational alterations of RBPs such as
HuR, BRF1, TTP, KSRP, TIAR/TIA-1 have been
linked to changes in their subcellular localization and
their association with and inﬂuence upon target mRNAs
(reviewed in 5,71).
Functional consequences, concluding remarks
In closing, many of nucleolin’s target mRNAs, including
those that bear the G-rich signature, encode proteins
involved in cell growth and proliferation, cancer and
viral infection. Whether nucleolin’s inﬂuence upon these
target transcripts is modulated by its interactions with
other RBPs and/or non-coding RNA awaits systematic
study. Another open question is how post-translational
modiﬁcation of nucleolin alters its inﬂuence on target
mRNAs. Finally, it remains to be tested whether the
promising clinical inﬂuence of AS1411, a nucleolin-
directed oligonucleotide, involves nucleolin’s effect on
targets that bear G-rich motifs. Addressing these ques-
tions in depth will provide critical information about the
role of nucleolin in cell proliferation and its potential use-
fulness in cancer therapy.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
FUNDING
National Institute on Aging-Intramural Research
Program of the National Institutes of Health; NIH
(RO1 1CA116491-01 to F.C.). Funding for open access
charge: National Institute on Aging-Intramural Research
Program, National Institutes of Health.
Conﬂict of interest statement. None declared.
REFERENCES
1. Moore,M.J. (2005) From birth to death: the complex lives of
eukaryotic mRNAs. Science, 309, 1514–1518.
2. Glisovic,T., Bachorik,J.L., Yong,J. and Dreyfuss,G. (2008)
RNA-binding proteins and post-transcriptional gene regulation.
FEBS Lett., 582, 1977–1986.
3. Mitchell,P. and Tollervey,D. (2000) mRNA stability in
eukaryotes. Curr. Opin. Genet. Dev., 10, 193–198.
4. Orphanides,G. and Reinberg,D. (2002) A uniﬁed theory of gene
expression. Cell, 108, 439–451.
5. Abdelmohsen,K., Kuwano,Y., Kim,H.H. and Gorospe,M. (2008)
Posttranscriptional gene regulation by RNA-binding proteins
during oxidative stress: implications for cellular senescence.
Biol. Chem., 389, 243–255.
6. Carballo,E., Lai,W.S. and Blackshear,P.J. (1998) Feedback
inhibition of macrophage tumor necrosis factor-a production
by tristetraprolin. Science, 281, 1001–1005.
7. Chen,C.Y., Gherzi,R., Ong,S.E., Chan,E.L., Raijmakers,R.,
Pruijn,G.J., Stoecklin,G., Moroni,C., Mann,M. and Karin,M.
(2001) AU binding proteins recruit the exosome to degrade
ARE-containing mRNAs. Cell, 107, 451–464.
8. Briata,P., Forcales,S.V., Ponassi,M., Corte,G., Chen,C.Y.,
Karin,M., Puri,P.L. and Gherzi,R. (2005) p38-dependent
phosphorylation of the mRNA decay-promoting factor KSRP
controls the stability of select myogenic transcripts. Mol. Cell, 20,
891–903.
9. Hinman,M.N. and Lou,H. (2008) Diverse molecular functions of
Hu proteins. Cell. Mol. Life Sci., 65, 3168–3181.
10. Zhang,W., Wagner,B.J., Ehrenman,K., Schaefer,A.W.,
De-Maria,C.T., Crater,D., DeHaven,K., Long,L. and Brewer,G.
(1993) Puriﬁcation, characterization, and cDNA cloning of an
AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol.,
13, 7652–7665.
11. Liao,B., Hu,Y. and Brewer,G. (2007) Competitive binding of
AUF1 and TIAR to MYC mRNA controls its translation.
Nat. Struct. Mol. Biol., 14, 511–518.
12. Mazan-Mamczarz,K., Kuwano,Y., Zhan,M., White,E.J.,
Martindale,J.L., Lal,A. and Gorospe,M. (2009) Identiﬁcation of a
signature motif in target mRNAs of RNA-binding protein AUF1.
Nucleic Acids Res., 37, 204–214.
13. Sarkar,B., Xi,Q., He,C. and Schneider,R.J. (2003) Selective
degradation of AU-rich mRNAs promoted by the p37 AUF1
protein isoform. Mol. Cell. Biol., 23, 6685–6693.
14. Piecyk,M., Wax,S., Beck,A.R., Kedersha,N., Gupta,M.,
Maritim,B., Chen,S., Gueydan,C., Kruys,V., Streuli,M. et al.
(2000) TIA-1 is a translational silencer that selectively regulates
the expression of TNF-a. EMBO J., 19, 4154–4163.
15. Lo ´ pez de Silanes,I., Galba ´ n,S., Martindale,J.L., Yang,X.,
Mazan-Mamczarz,K., Indig,F.E., Falco,G., Zhan,M. and
Gorospe,M. (2005) Identiﬁcation and functional outcome of
mRNAs associated with RNA-binding protein TIA-1. Mol. Cell.
Biol., 25, 9520–9531.
16. Lal,A., Abdelmohsen,K., Pullmann,R., Kawai,T., Yang,X.,
Galban,S., Brewer,G. and Gorospe,M. (2006) Posttranscriptional
derepression of GADD45a by genotoxic stress. Mol. Cell, 22,
117–128.
17. Sawicka,K., Bushell,M., Spriggs,K.A. and Willis,A.E. (2008)
Polypyrimidine-tract-binding protein: a multifunctional
RNA-binding protein. Biochem. Soc. Trans., 36, 641–647.
18. Galba ´ n,S., Kuwano,Y., Pullmann,R. Jr, Martindale,J.L.,
Kim,H.H., Lal,A., Abdelmohsen,K., Yang,X., Dang,X., Liu,J.O.
et al. (2008) RNA-binding proteins HuR and PTB promote the
translation of hypoxia-inducible factor 1alpha. Mol. Cell. Biol.,
28, 93–107.
19. Kuwano,Y., Pullmann,R. Jr, Marasa,B.S., Abdelmohsen,K.,
Lee,E.K., Yang,X., Martindale,J.L., Zhan,M. and Gorospe,M.
8528 Nucleic Acids Research, 2011,Vol.39, No. 19(2009) NF90 selectively represses the translation of target
mRNAs bearing an AU-rich signature motif. Nucleic Acids Res.,
38, 225–238.
20. Corthesy,B. and Kao,P.N. (1994) Puriﬁcation by DNA afﬁnity
chromatography of two polypeptides that contact the NF-AT
DNA binding site in the interleukin 2 promoter. J. Biol. Chem.,
269, 20682–20690.
21. Ginisty,H., Sicard,H., Roger,B. and Bouvet,P. (1999) Structure
and functions of nucleolin. J. Cell. Sci., 112, 761–772.
22. Tuteja,R. and Tuteja,N. (1998) Nucleolin: a multifunctional major
nucleolar phosphoprotein. Crit. Rev. Biochem. Mol. Biol., 33,
407–436.
23. Mongelard,F. and Bouvet,P. (2007) Nucleolin: a multiFACeTed
protein. Trends Cell. Biol., 17, 80–86.
24. Johansson,C., Finger,L.D., Trantirek,L., Mueller,T.D., Kim,S.,
Laird-Offringa,I.A. and Feigon,J. (2004) Solution structure of the
complex formed by the two N-terminal RNA-binding domains of
nucleolin and a pre-rRNA target. J. Mol. Biol., 337, 799–816.
25. Angelov,D., Bondarenko,V.A., Almagro,S., Menoni,H.,
Mongelard,F., Hans,F., Mietton,F., Studitsky,V.M., Hamiche,A.,
Dimitrov,S. et al. (2006) Nucleolin is a histone chaperone with
FACT-like activity and assists remodeling of nucleosomes.
EMBO J., 25, 1669–1679.
26. Wang,Y., Guan,J., Wang,H., Wang,Y., Leeper,D. and Iliakis,G.
(2001) Regulation of DNA replication after heat shock by
replication protein a-nucleolin interactions. J. Biol. Chem., 276,
20579–20588.
27. Bouvet,P., Allain,F.H., Finger,L.D., Dieckmann,T. and Feigon,J.
(2001) Recognition of pre-formed and ﬂexible elements of an
RNA stem-loop by nucleolin. J. Mol. Biol., 309, 763–775.
28. Serin,G., Joseph,G., Faucher,C., Ghisolﬁ,L., Bouche,G.,
Amalric,F. and Bouvet,P. (1996) Localization of nucleolin binding
sites on human and mouse pre-ribosomal RNA. Biochimie, 78,
530–538.
29. Ginisty,H., Amalric,F. and Bouvet,P. (1998) Nucleolin functions
in the ﬁrst step of ribosomal RNA processing. EMBO J., 17,
1476–1486.
30. Srivastava,M. and Pollard,H.B. (1999) Molecular dissection of
nucleolin’s role in growth and cell proliferation: new insights.
FASEB J., 13, 1911–1922.
31. Take,M., Tsutsui,J., Obama,H., Ozawa,M., Nakayama,T.,
Maruyama,I., Arima,T. and Muramatsu,T. (1994) Identiﬁcation
of nucleolin as a binding protein for midkine (MK) and
heparin-binding growth associated molecule (HB-GAM).
J. Biochem., 116, 1063–1068.
32. Hovanessian,A.G. (2006) Midkine, a cytokine that inhibits
HIV infection by binding to the cell surface expressed nucleolin.
Cell Res., 16, 174–181.
33. Said,E.A., Courty,J., Svab,J., Delbe,J., Krust,B. and
Hovanessian,A.G. (2005) Pleiotrophin inhibits HIV infection
by binding the cell surface-expressed nucleolin. FEBS J., 272,
4646–4659.
34. Mellgren,R.L. (2010) A plasma membrane wound proteome:
reversible externalization of intracellular proteins following
reparable mechanical damage. J. Biol. Chem., 285, 36597–36607.
35. Sagou,K., Uema,M. and Kawaguchi,Y. (2010) Nucleolin is
required for efﬁcient nuclear egress of herpes simplex virus type 1
nucleocapsids. J. Virol., 84, 2110–2121.
36. Izumi,R.E., Valdez,B., Banerjee,R., Srivastava,M. and
Dasgupta,A. (2001) Nucleolin stimulates viral internal ribosome
entry site-mediated translation. Virus Res., 76, 17–29.
37. Malter,J.S. (2001) Regulation of mRNA stability in the nervous
system and beyond. J. Neurosci. Res., 66, 311–316.
38. Chen,C.Y., Gherzi,R., Andersen,J.S., Gaietta,G., Ju ¨ rchott,K.,
Royer,H.D., Mann,M. and Karin,M. (2000) Nucleolin and YB-1
are required for JNK-mediated interleukin-2 mRNA stabilization
during T-cell activation. Genes Dev., 14, 1236–1248.
39. Sengupta,T.K., Bandyopadhyay,S., Fernandes,D.J. and
Spicer,E.K. (2004) Identiﬁcation of nucleolin as an AU-rich
element binding protein involved in bcl-2 mRNA stabilization.
J. Biol. Chem., 279, 10855–10863.
40. Otake,Y., Soundararajan,S., Sengupta,T.K., Kio,E.A., Smith,J.C.,
Pineda-Roman,M., Stuart,R.K., Spicer,E.K. and Fernandes,D.J.
(2007) Overexpression of nucleolin in chronic lymphocytic
leukemia cells induces stabilization of bcl2 mRNA. Blood, 109,
3069–3075.
41. Jiang,Y., Xu,X.S. and Russell,J.E. (2006) A nucleolin-binding
30 untranslated region element stabilizes beta-globin mRNA
in vivo. Mol. Cell. Biol., 26, 2419–2429.
42. Rajagopalan,L.E., Westmark,C.J., Jarzembowski,J.A. and
Malter,J.S. (1998) hnRNP C increases amyloid precursor protein
(APP) production by stabilizing APP mRNA. Nucleic Acids Res.,
26, 3418–3423.
43. Lee,P.T., Liao,P.C., Chang,W.C. and Tseng,J.T. (2007) Epidermal
growth factor increases the interaction between nucleolin and
heterogeneous nuclear ribonucleoprotein K/poly(C) binding
protein 1 complex to regulate the gastrin mRNA turnover.
Mol. Biol. Cell, 18, 5004–5013.
44. Zhang,Y., Bhatia,D., Xia,H., Castranova,V., Shi,X. and Chen,F.
(2006) Nucleolin links to arsenic-induced stabilization of
GADD45alpha mRNA. Nucleic Acids Res., 34, 485–495.
45. Takagi,M., Absalon,M.J., McLure,K.G. and Kastan,M.B. (2005)
Regulation of p53 translation and induction after DNA damage
by ribosomal protein L26 and nucleolin. Cell, 123, 49–63.
46. Bunimov,N., Smith,J.E., Gosselin,D. and Laneuville,O. (2007)
Translational regulation of PGHS-1 mRNA: 50 untranslated
region and ﬁrst two exons conferring negative regulation.
Biochim. Biophys. Acta, 1769, 92–105.
47. Fahling,M., Steege,A., Perlewitz,A., Nafz,B., Mrowka,R.,
Persson,P.B. and Thiele,B.J. (2005) Role of nucleolin in
posttranscriptional control of MMP-9 expression. Biochim.
Biophys. Acta, 1731, 32–40.
48. Miniard,A.C., Middleton,L.M., Budiman,M.E., Gerber,C.A. and
Driscoll,D.M. (2010) Nucleolin binds to a subset of selenoprotein
mRNAs and regulates their expression. Nucleic Acids Res., 38,
4807–4820.
49. Abdelmohsen,K., Srikantan,S., Yang,X., Lal,A., Kim,H.H.,
Kuwano,Y., Galban,S., Becker,K.G., Kamara,D., de Cabo,R.
et al. (2009) Ubiquitin-mediated proteolysis of HuR by heat
shock. EMBO J., 28, 1271–1282.
50. Gorodkin,J., Heyer,L.J. and Stormo,G.D. (1997) Finding the
most signiﬁcant common sequence and structure motifs in a set
of RNA sequences. Nucleic Acids Res., 25, 3724–3732.
51. Eddy,S.R. and Durbin,R. (1994) RNA sequence analysis using
covariance models. Nucleic Acids Res., 22, 2079–2088.
52. Abdelmohsen,K., Srikantan,S., Kuwano,Y. and Gorospe,M.
(2008) miR-519 reduces cell proliferation by lowering
RNA-binding protein HuR levels. Proc. Natl Acad. Sci. USA,
105, 20297–20302.
53. Kim,H.H. and Gorospe,M. (2008) GU-rich RNA: expanding
CUGBP1 function, broadening mRNA turnover. Mol. Cell, 29,
151–152.
54. Zhang,J., Tsaprailis,G. and Bowden,G.T. (2008) Nucleolin
stabilizes Bcl-X L messenger RNA in response to UVA
irradiation. Cancer Res., 68, 1046–1054.
55. Soundararajan,S., Chen,W., Spicer,E.K., Courtenay-Luck,N. and
Fernandes,D.J. (2008) The nucleolin targeting aptamer AS1411
destabilizes Bcl-2 messenger RNA in human breast cancer cells.
Cancer Res., 68, 2358–2365.
56. Ishimaru,D., Zuraw,L., Ramalingam,S., Sengupta,T.K.,
Bandyopadhyay,S., Reuben,A., Fernandes,D.J. and Spicer,E.K.
(2010) Mechanism of regulation of bcl-2 mRNA by nucleolin and
A+U-rich element-binding factor 1 (AUF1). J. Biol. Chem., 285,
27182–27191.
57. Mongelard,F. and Bouvet,P. (2010) AS-1411, a guanosine-rich
oligonucleotide aptamer targeting nucleolin for the potential
treatment of cancer, including acute myeloid leukemia. Curr.
Opin. Mol. Ther., 12, 107–114.
58. Lopez de Silanes,I., Zhan,M., Lal,A., Yang,X. and Gorospe,M.
(2004) Identiﬁcation of a target RNA motif for RNA-binding
protein HuR. Proc. Natl Acad. Sci. USA, 101, 2987–2992.
59. Kuwano,Y., Pullmann,R. Jr, Marasa,B.S., Abdelmohsen,K.,
Lee,E.K., Yang,X., Martindale,J.L., Zhan,M. and Gorospe,M.
(2010) NF90 selectively represses the translation of target mRNAs
bearing an AU-rich signature motif. Nucleic Acids Res., 38,
225–238.
60. Al-Souhibani,N., Al-Ahmadi,W., Hesketh,J.E., Blackshear,P.J.
and Khabar,K.S. (2010) The RNA-binding zinc-ﬁnger protein
Nucleic Acids Research, 2011,Vol.39, No. 19 8529tristetraprolin regulates AU-rich mRNAs involved in breast
cancer-related processes. Oncogene, 29, 4205–4215.
61. Raineri,I., Wegmueller,D., Gross,B., Certa,U. and Moroni,C.
(2004) Roles of AUF1 isoforms, HuR and BRF1 in
ARE-dependent mRNA turnover studied by RNA interference.
Nucleic Acids Res., 32, 1279–1288.
62. Fahling,M., Mrowka,R., Steege,A., Nebrich,G., Perlewitz,A.,
Persson,P.B. and Thiele,B.J. (2006) Translational control of
collagen prolyl 4-hydroxylase-alpha(I) gene expression under
hypoxia. J. Biol. Chem., 281, 26089–26101.
63. Mikulits,W., Pradet-Balade,B., Habermann,B., Beug,H.,
Garcia-Sanz,J.A. and Mu ¨ llner,E.W. (2000) Isolation of
translationally controlled mRNAs by differential screening.
FASEB J., 14, 1641–1652.
64. Ingolia,N.T., Ghaemmaghami,S., Newman,J.R. and Weissman,J.S.
(2009) Genome-wide analysis in vivo of translation with
nucleotide resolution using ribosome proﬁling. Science, 324,
218–223.
65. Lee,E.K. and Gorospe,M. (2011) Coding region: The neglected
post-transcriptional code. RNA Biol., 8, January/February 2011
(doi:10.4161/rna.8.1.13863; epub ahead of print).
66. Yang,C., Maiguel,D.A. and Carrier,F. (2002) Identiﬁcation of
nucleolin and nucleophosmin as genotoxic stress-responsive
RNA-binding proteins. Nucleic Acids Res., 30, 2251–2260.
67. Klibanov,S.A., O’Hagan,H.M. and Ljungman,M. (2001)
Accumulation of soluble and nucleolar-associated p53 proteins
following cellular stress. J. Cell Sci., 114, 1867–1873.
68. Hollander,B.A., Liang,M.Y. and Besharse,J.C. (1999) Linkage of
a nucleolin-related protein and casein kinase II with the
detergent-stable photoreceptor cytoskeleton. Cell. Motil.
Cytoskeleton, 43, 114–127.
69. Zhou,G., Seibenhener,M.L. and Wooten,M.W. (1997) Nucleolin is
a protein kinase C-zeta substrate. Connection between cell surface
signaling and nucleus in PC12 cells. J. Biol. Chem., 272,
31130–31137.
70. Belenguer,P., Caizergues-Ferrer,M., Labbe,J.C., Doree,M. and
Amalric,F. (1990) Mitosis-speciﬁc phosphorylation of nucleolin by
p34cdc2 protein kinase. Mol. Cell. Biol., 10, 3607–3618.
71. Srikantan,S. and Gorospe,M. (2008) Regulation of mRNA
turnover by cellular stress. In Bradshaw,R.A. and Dennis,E.A.
(eds), Handbook of Cell Signaling, chapter 270.
8530 Nucleic Acids Research, 2011,Vol.39, No. 19